| value |
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1699350/0002070582-26-000003.txt","as_of":"2026-04-22T03:03:32.063787+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1699350/0002070582-26-000003.txt","company":"SHOULDER INNOVATIONS, INC.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1699350/0002070582-26-000003.txt","article_chars":2546,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_2f9cd5254d3f11eb","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1699350/0002070582-26-000003.txt","content_type":"text/plain","enriched_at":"2026-04-22T03:29:46.185568+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1699350/0002070582-26-000003.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1699350/0002070582-26-000003.txt","source_event_id":"evt_43cde4609abe","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"9abd0140807414c8","kind":"sec_filing","published_at":"20260421","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-21","2026-04-20","2024-04-19","2026-04-01","2026-06-30","2033-05-09","2035-04-23"],"entities":[{"asset_class":"equity","name":"SHOULDER INNOVATIONS, INC.","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"equity","name":"Matthew Fraser Ahearn","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"equity","name":"Genesis Investment Holdings","relevance":"medium","symbol":"","type":"counterparty_in_kind_distribution"},{"asset_class":"equity","name":"cultivate(MD) Capital Accelerator Fund, L.P.","relevance":"medium","symbol":"","type":"counterparty_in_kind_distribution"},{"asset_class":"equity","name":"Cultivate MD Capital Fund I, LLC","relevance":"medium","symbol":"","type":"counterparty_in_kind_distribution"},{"asset_class":"equity","name":"Cultivate MD Capital Fund II, LP","relevance":"medium","symbol":"","type":"counterparty_in_kind_distribution"}],"event_type":"listing","information_gaps":["The provided text does not explicitly state the exact number of shares acquired/disposed in this specific Form 4 (it shows option/common stock lines but does not clearly label the transaction type beyond the in-kind distribution statement).","The \u201cwhat changed vs prior known state\u201d is only partially addressed: the text references prior beneficial ownership of 215,856 shares held directly, but it does not provide the updated beneficial ownership figure in the excerpt.","Exercise prices and underlying share counts for the stock options are present in the raw lines (e.g., \u201c2.4804\u201d and \u201c2.862\u201d), but the excerpt does not clearly map each price to a specific underlying share count in a fully labeled way beyond the visible numeric fragments."],"key_facts":["SEC Form 4 (CONFORMED SUBMISSION TYPE: 4) was filed as of 2026-04-21 for Shoulder Innovations, Inc., with conform ed period of report 2026-04-20.","Reporting person: Matthew Fraser Ahearn (Chief Operating Officer).","The filing includes transactions/holdings in Common Stock and Stock Option (two option entries shown with different underlying share counts and exercise prices).","The text states: \u201cIncludes the following shares received without consideration as in-kind distributions: (i) 39,404 shares from Genesis Investment Holdings; (ii) 1,572 shares from cultivate(MD) Capital Accelerator Fund, L.P.; (iii) 4,400 shares from Cultivate MD Capital Fund I, LLC; and (iv) 3,869 shares from Cultivate MD Capital Fund II, LP.\u201d","The text states: \u201cIn prior reports, the reporting person reported beneficial ownership of 215,856 shares of Shoulder Innovations common stock held directly.\u201d","Vesting schedule described for one stock option: \u201cvested as to one-fourth of the underlying shares on April 19, 2024, and the remaining shares vest in 36 equal increments on the last day of each calendar month thereafter.\u201d","A second vesting schedule described: \u201cThe stock option vested as to one-fourth of the underlying shares on April 1, 2026, and the remaining shares vest in 12 equal increments on the last day of each fiscal quarter beginning on June 30, 2026.\u201d","Signature: \u201c/s/ Jeffrey Points, as Attorney-in-Fact\u201d dated 2026-04-21."],"numeric_claims":[{"label":"Form 4 filed as of date","value":"2026-04-21"},{"label":"Conformed period of report","value":"2026-04-20"},{"label":"Prior beneficial ownership (direct)","value":"215,856 shares"},{"label":"In-kind distribution shares from Genesis Investment Holdings","value":"39,404"},{"label":"In-kind distribution shares from cultivate(MD) Capital Accelerator Fund, L.P.","value":"1,572"},{"label":"In-kind distribution shares from Cultivate MD Capital Fund I, LLC","value":"4,400"},{"label":"In-kind distribution shares from Cultivate MD Capital Fund II, LP","value":"3,869"}],"primary_claim":"Form 4 for SHOULDER INNOVATIONS, INC. was filed on 2026-04-21 (covering period 2026-04-20) by Matthew Fraser Ahearn, disclosing common stock and stock option holdings/vesting and in-kind distributions of shares.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Shoulder Innovations, Inc. reported a Form 4 filed on 2026-04-21 by reporting person Matthew Fraser Ahearn. The filing discloses stock option-related transactions/ownership changes tied to common stock and includes vesting schedules and in-kind distributions of shares.","topics":["SEC Form 4","insider ownership","stock options","vesting schedule","in-kind distributions","beneficial ownership"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 SHOULDER INNOVATIONS, INC. \u00b7 Filed 20260421","ticker":"SI","tickers":["SI"],"title":"SI filed 4","url":"https://www.sec.gov/Archives/edgar/data/1699350/0002070582-26-000003.txt"}... |